Search 

Innokas Medical provides services on product development, manufacturing and life-cycle management for world class medical devices. We are focused on medical devices and have tailored our processes to meet the needed quality and regulatory requirements.

We are developing a new carephone that integrates extended battery life and GSM module.

• The company is managed by its three founding members
• TUOHI carephone’s development started in 2013
• Extended battery life (micro amperage power consumption) and GSM module integration form the product's core
• Customers’ requirements contribute the rest of the design
• Field testing in Q1-Q2 2014
• Commercialization in Q3-Q4 2014
• The Finnish government has granted 50 000 euro development subsidy for the FY2013 through ELY

Founded by faculty from Tallinn University of Technology in Estonia, IoT Technologies is commercializing a decade of research focused on distributed sensing / computing technology. The technology was initially applied to defense applications (see Defendec (www.defendec.com)). We are now taking the technology to the healthcare domain, more specifically to wellness monitoring, helping family members, caregivers and physicians to obtain a better understanding of the health of the person.

Magnasense Technologies Oy

Superior immunoassay performance utilising paramagnetic labels - MagneticImmunoAssay (MIA).

Magnasense has developed a sensitive, simple and elegant system for performing lateral flow immunoassays utilising paramagnetic particles as labels.

Biological materials contain no background magnetism, enabling great sensitivity, while the elimination of chemical, enzymatic and fluorescent reagents simplifies the assay procedure.

The magnetic label interacts directly with the reader’s electronics eliminating the need for light sources and optics.

The above factors provide a uniquely sensitive, robust and inexpensive system.

The system is widely applicable. Quantitative, Near Patient / Point of Care (POC) assays and tests can be rapidly developed with high sensitivity and dynamic ranges of over four decades.
Healthcare applications include cardiac monitoring, e.g. hsCRP and infectious diseases, e.g. viruses.

Outside healthcare, assays can be developed for other applications where rapid results are required, such as veterinary testing, and food and environmental contamination

Applications:
Near Patient Testing, Point of Care Testing, Veterinary Testing, Mould / Mycotoxin testing, Food adulteration, Environmental testing

Mainstay is a unique venture-backed active implantable medical device company with a new proprietary device for treatment of people with chronic low back pain. Results from a European Feasibility Study developed very encouraging results.

Medxense offers accurate continuous glucose monitoring for the intensive care unit (ICU). Normalization of patient blood glucose allows hospitals to reduce mortality and patient length of stay. 

The patented sensor technology platform is the only in the field to offer both high accuracy and near-instantaneous measurements in the hypoglycemic range, necessary for safe normalization of blood glucose.

We are now looking for an investment of 3 MUSD to fund clinical trials in the 2nd half of 2014. Expected exits are trade sale or IPO.

Mendor - the new diabetes movement

Mendor is a diabetes technology company with two main products:
1. Mendor Discreet - a globally unique all-in-one integrated glucose meter
2. Mendor Balance - a cloud-based glucose profiling & diabetes management platform for clinics, HCPs & diabetics.

Our key partners include:
Menarini Diagnostics, Merck Serono, Sanofi & Lilly.

Our revenue history:
2011: 0,2M€
2012: 0,6M€
2013 01-07: 3,2M€

Company presentation with some more details:
https://www.dropbox.com/sh/ycp289w4g8wmqwn/0Yj457jnK8/Mendor_Company_Presentation-Aug_2013.pdf